Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

EFFECTS OF α-CHYMOTRYPSIN

EFFECTS OF α-CHYMOTRYPSIN This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor: I read with considerable interest Dr. Michael Hogan's remarks concerning possible deleterious effects of α-chymotrypsin.It might have been more to the point had Dr. Hogan edited the commercial query to read, "Alpha si ? o Alpha no ?". However, since Dr. Joaquin Barraquer is equally fluent in French I am sure that only deGaulle would be upset.I agree with Dr. Hogan that it is time for a scientific reevaluation of the long-term effect of α-chymotrypsin. We should cease to condemn zonulolysis out of hand as a cause of complications which may be only coincidental. Certainly, enough evidence of directly related problems has been accumulated to warrant a full-scale investigation.In assessing our results, however, we must not lose sight of the fact that α-chymotrypsin has contributed more to cataract surgery than the lysis of the zonule. It has served to stimulate interest and enthusiasm in the cataract http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Ophthalmology American Medical Association

EFFECTS OF α-CHYMOTRYPSIN

Archives of Ophthalmology , Volume 76 (5) – Nov 1, 1966

EFFECTS OF α-CHYMOTRYPSIN

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor: I read with considerable interest Dr. Michael Hogan's remarks concerning possible deleterious effects of α-chymotrypsin.It might have been more to the point had Dr. Hogan edited the commercial query to read, "Alpha si ? o Alpha no ?". However, since Dr. Joaquin Barraquer is equally fluent in French I am sure that...
Loading next page...
 
/lp/american-medical-association/effects-of-chymotrypsin-zRLLxOBNAP
Publisher
American Medical Association
Copyright
Copyright © 1966 American Medical Association. All Rights Reserved.
ISSN
0003-9950
eISSN
1538-3687
DOI
10.1001/archopht.1966.03850010766024
Publisher site
See Article on Publisher Site

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor: I read with considerable interest Dr. Michael Hogan's remarks concerning possible deleterious effects of α-chymotrypsin.It might have been more to the point had Dr. Hogan edited the commercial query to read, "Alpha si ? o Alpha no ?". However, since Dr. Joaquin Barraquer is equally fluent in French I am sure that only deGaulle would be upset.I agree with Dr. Hogan that it is time for a scientific reevaluation of the long-term effect of α-chymotrypsin. We should cease to condemn zonulolysis out of hand as a cause of complications which may be only coincidental. Certainly, enough evidence of directly related problems has been accumulated to warrant a full-scale investigation.In assessing our results, however, we must not lose sight of the fact that α-chymotrypsin has contributed more to cataract surgery than the lysis of the zonule. It has served to stimulate interest and enthusiasm in the cataract

Journal

Archives of OphthalmologyAmerican Medical Association

Published: Nov 1, 1966

There are no references for this article.